Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics

LR Forte Jr - Pharmacology & therapeutics, 2004 - Elsevier
Guanylin, uroguanylin, and the bacterial heat-stable enterotoxin (ST) peptides comprise a
new family of cyclic guanosine 3′-5′ monophosphate (cGMP)-regulating agonists. The …

Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance

Z Panteleakou, P Lembessis, A Sourla, N Pissimissis… - Molecular …, 2009 - Springer
Disseminated malignancy is the major cause of prostate cancer-related mortality. Circulating
tumor cells (CTCs) are essential for the establishment of metastasis. Various contemporary …

Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT) and standard density gradient

CP Corkum, DP Ings, C Burgess, S Karwowska… - BMC immunology, 2015 - Springer
Background High quality genetic material is an essential pre-requisite when analyzing gene
expression using microarray technology. Peripheral blood mononuclear cells (PBMC) are …

Methods of in situ detection of nucleic acids

Y Luo, HY Wang, JJ Flanagan… - US Patent App. 13/575,936, 2013 - Google Patents
Methods of detecting the presence or absence of a class of nucleic acid targets in single
cells through direct or indirect capture of labels to the nucleic acids are provided, where …

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients

AE Snook, TR Baybutt, B Xiang, TS Abraham… - … for Immunotherapy of …, 2019 - Springer
Background The colorectal cancer antigen GUCY2C exhibits unique split tolerance, evoking
antigen-specific CD8+, but not CD4+, T-cell responses that deliver anti-tumor immunity …

Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review

S Vafaei, F Fattahi, M Ebrahimi, L Janani… - Cancer management …, 2019 - Taylor & Francis
Nearly half of patients with colorectal cancer (CRC), the third leading cause of cancer deaths
worldwide, are diagnosed in the late stages of the disease. Appropriate treatment is not …

Molecular detection of circulating cancer cells: Role in diagnosis, prognosis and follow-up of colon cancer patients

B Molnar, F Sipos, O Galamb, Z Tulassay - Digestive diseases, 2003 - karger.com
Background: The circulating tumor cells of solid tumors, especially in colorectal cancer has
been of great interest in medical research in the last and new century. Methods: A literature …

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer

GS Frick, GM Pitari, DS Weinberg… - Expert review of …, 2005 - Taylor & Francis
Staging patients with colorectal cancer defines their prognosis and therapeutic
management. Unfortunately, histopathology, the current standard for staging, is relatively …

Methods of detecting nucleic acid sequences with high specificity

Y Luo, JJ Flanagan, N Su, HYF Wang - 2011 - Google Patents
The invention relates to methods of detecting nucleic acids, including methods of detecting
one or more target nucleic acid sequences in multiplex branched-chain DNA assays, are …

[HTML][HTML] Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients

A Tsouma, C Aggeli, P Lembessis… - World journal of …, 2010 - ncbi.nlm.nih.gov
AIM: To develop a multiplex reverse transcription polymerase chain reaction (RT-PCR)
method detecting circulating tumor cells in the peripheral blood of colorectal cancer (CRC) …